Resistance	Microbe	Outcome
Ampicillin /	Campylobacter spp.	See: Table 5 AMR+ (%) AMR- (%) Total (n) Intensive 72.90 83 Extensive indoor 74.80 41
Amoxicillin And Beta-Lactamase Inhibitor /	Campylobacter spp.	See: Table 5 AMR+ (%) AMR- (%) Total (n) Intensive 2.70 83 Extensive indoor 56.70 41
Ciprofloxacin /	Campylobacter spp.	See: Table 5 AMR+ (%) AMR- (%) Total (n) Intensive 96.40 83 Extensive indoor 77.40 41
Norfloxacin /	Campylobacter spp.	See: Table 5 AMR+ (%) AMR- (%) Total (n) Intensive 95.90 83 Extensive indoor 74.00 41
Ofloxacin /	Campylobacter spp.	See: Table 5 AMR+ (%) AMR- (%) Total (n) Intensive 95.40 83 Extensive indoor 58.30 41
Nalidixic Acid /	Campylobacter spp.	See: Table 2 AMR+ (%) AMR- (%) Total (n) Intensive 97.90 83 Extensive indoor 87.70 41
Erythromycin /	Campylobacter spp.	See: Table 2 AMR+ (%) AMR- (%) Total (n) Intensive 25.60 83 Extensive indoor 16.20 41
Tetracycline /	Campylobacter spp.	See: Table 5 AMR+ (%) AMR- (%) Total (n) Intensive 82.90 83 Extensive indoor 40.80 41
Sulfamethoxazole And Trimethoprim /	Campylobacter spp.	See: Table 5 AMR+ (%) AMR- (%) Total (n) Intensive 48.60 83 Extensive indoor 48.00 41
Chloramphenicol /	Campylobacter spp.	See: Table 5 AMR+ (%) AMR- (%) Total (n) Intensive 0.80 83 Extensive indoor 7.10 41
Gentamicin /	Campylobacter spp.	See: Table 5 AMR+ (%) AMR- (%) Total (n) Intensive 0.80 83 Extensive indoor 44.20 41